These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6121857)

  • 1. The kinetics of inhibition of type-B monoamine oxidase by clorgyline, pargyline and (-)-deprenyl.
    Green AL
    J Pharm Pharmacol; 1981 Dec; 33(12):798-800. PubMed ID: 6121857
    [No Abstract]   [Full Text] [Related]  

  • 2. The acetylenic monoamine oxidase inhibitors clorgyline, deprenyl, pargyline and J-508: their properties and applications.
    Fowler CJ; Oreland L; Callingham BA
    J Pharm Pharmacol; 1981 Jun; 33(6):341-7. PubMed ID: 6115003
    [No Abstract]   [Full Text] [Related]  

  • 3. The nature of the inhibition of rat liver monoamine oxidase types A and B by the acetylenic inhibitors clorgyline, l-deprenyl and pargyline.
    Fowler CJ; Mantle TJ; Tipton KF
    Biochem Pharmacol; 1982 Nov; 31(22):3555-61. PubMed ID: 6817759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of MAO-A activity enhances behavioural activity of rats assessed using water maze and open arena tasks.
    Barbelivien A; Nyman L; Haapalinna A; Sirviö J
    Pharmacol Toxicol; 2001 Jun; 88(6):304-12. PubMed ID: 11453370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyroid iodide transport is reduced by administration of monoamine oxidase A inhibitors to rats.
    Cabanillas AM; Masini-Repiso AM; Costamagna ME; Pellizas C; Coleoni AH
    J Endocrinol; 1994 Nov; 143(2):303-8. PubMed ID: 7829993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of inhibitors of monoamine oxidase activity in goldfish (Carassius auratus) brain in vitro.
    Figueroa HR; Hall TR; Olcese JM; de Vlaming VL
    Comp Biochem Physiol C Comp Pharmacol; 1981; 70(2):281-4. PubMed ID: 6118229
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of long-term treatment with selective monoamine oxidase A and B inhibitors on dopamine release from rat striatum in vivo.
    Lamensdorf I; Youdim MB; Finberg JP
    J Neurochem; 1996 Oct; 67(4):1532-9. PubMed ID: 8858937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potentiation of para-hydroxyamphetamine-induced head-twitch response by inhibition of monoamine oxidase type A in the brain.
    Tadano T; Satoh S; Satoh N; Kisara K; Arai Y; Kim SK; Kinemuchi H
    J Pharmacol Exp Ther; 1989 Jul; 250(1):254-60. PubMed ID: 2501477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of the absolute concentrations of monoamine oxidase A and B in human tissues.
    O'Carroll AM; Anderson MC; Tobbia I; Phillips JP; Tipton KF
    Biochem Pharmacol; 1989 Mar; 38(6):901-5. PubMed ID: 2495009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selectivity of clorgyline and pargyline as inhibitors of monoamine oxidases A and B in vivo in man.
    Murphy DL; Lipper S; Slater S; Shiling D
    Psychopharmacology (Berl); 1979 Apr; 62(2):129-32. PubMed ID: 111275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoamine oxidase inhibitors l-deprenyl and clorgyline protect nonmalignant human cells from ionising radiation and chemotherapy toxicity.
    Seymour CB; Mothersill C; Mooney R; Moriarty M; Tipton KF
    Br J Cancer; 2003 Nov; 89(10):1979-86. PubMed ID: 14612913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic treatment with the monoamine oxidase inhibitors clorgyline and pargyline down-regulates non-adrenoceptor [3H]-idazoxan binding sites in the rat brain.
    Olmos G; Gabilondo AM; Miralles A; Escriba PV; García-Sevilla JA
    Br J Pharmacol; 1993 Mar; 108(3):597-603. PubMed ID: 8385528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of rat brain cytosolic monoamine oxidase activity by clorgyline. Comparison with (-)-deprenyl and MDL 72145.
    Azam M; Jain S; Baquer NZ
    Biochem Pharmacol; 1990 Nov; 40(10):2215-8. PubMed ID: 2123104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reciprocal changes in striatal dopamine and beta-phenylethylamine induced by reserpine in the presence of monoamine oxidase inhibitors.
    Juorio AV; Greenshaw AJ; Wishart TB
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Dec; 338(6):644-8. PubMed ID: 3149722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoamine oxidase-III. Further studies of inhibition by propargylamines.
    Williams CH; Lawson J
    Biochem Pharmacol; 1975 Oct; 24(20):1889-91. PubMed ID: 1191339
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of monoamine oxidase inhibitors on some arylalkylamines in rate striatum.
    Philips SR; Boulton AA
    J Neurochem; 1979 Jul; 33(1):159-67. PubMed ID: 572413
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of selective monoamine oxidase inhibitors on the in vivo release and metabolism of dopamine in the rat striatum.
    Butcher SP; Fairbrother IS; Kelly JS; Arbuthnott GW
    J Neurochem; 1990 Sep; 55(3):981-8. PubMed ID: 2117053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The aphrodisiac effect of low doses of (-) deprenyl in male rats.
    Yen TT; Dalló J; Knoll J
    Pol J Pharmacol Pharm; 1982; 34(5-6):303-8. PubMed ID: 6821215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of monoamine oxidase by clorgyline and deprenyl in circumventricular structures of rat brain.
    Kinemuchi H; Wakui Y; Arai Y; Kamijo K
    Biochem Pharmacol; 1980 Oct; 29(20):2871-4. PubMed ID: 6776962
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of mitochondrial monoamine oxidase of the rat uterus and liver by clorglyine, pargyline and harmine.
    Grosso DS; Gawienowski AM
    Biochem Pharmacol; 1976 Apr; 25(8):957-61. PubMed ID: 178322
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.